REX BIONICS PLC Rex Bionics plc
('Rex Bionics' or the 'Company')
Directors Interests
27 September 2016 Rex Bionics plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, announces that pursuant to the existing Deferred Bonus Share Plan (under which employees are issued options to subscribe for cash at par for Ordinary Shares in respect of the bonus to which they were otherwise entitled) the Company has made awards, for the financial year ended 31 March 2016, in respect of an aggregate of 791,279 Ordinary Shares of 10p each in the Company ('Ordinary Shares') (representing 3.1% of the current issued Ordinary Shares) to certain employees in the Company including the Chief Executive Officer, the Chief Financial Officer and the Chief Technology Officer.
The Awards to those Directors are as follows:
Name | Deferred Bonus Award Shares | |
Crispin Simon | 140,000 | |
Peter Worrall | 93,333 | |
Richard Little | 134,070 | |
For further information please contact:
Rex Bionics Plc
Peter Worrall, Chief Financial Officer
+44 (0) 142 864 5416
Stifel Securities Limited (NOMAD and Broker)
Jonathan Senior, Stewart Wallace, Ben Maddison
+44 (0) 20 7710 7600
Consilium Strategic Communications
Lindsey Neville
rexbionics@consilium-comms.com
+44 (0) 203 709 5700
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities/person closely associated |
(a) | Name: CRISPIN SIMON |
2. | Reason for the notification |
(a) | Position/status: CHIEF EXECUTIVE |
(b) | Initial notification/Amendment: INITIAL |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
(a) | Name: REX BIONICS plc |
(b) | LEI: NA |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
(a) | Description of the Financial instrument, type of instrument: Rex Bionics Option over Ordinary Shares of 10p each Identification code: ISIN: GB00BLRLQM66 |
(b) | Nature of the transaction: Issue of awards under Deferred Bonus Share Plan |
(c) | Price(s) and volume(s) Price(s): 10p per Ordinary Share Volume(s): 140,000 |
(d) | Aggregated information · Aggregated volume: 140,000 Ordinary Shares awarded · Price: Exercise price: 10p per Ordinary Share |
(e) | Date of the transaction: 27 September 2016 |
(f) | Place of the transaction: London Stock Exchange - AIM |
1. | Details of the person discharging managerial responsibilities/person closely associated |
(a) | Name: PETER WORRALL |
2. | Reason for the notification |
(a) | Position/status: CHIEF FINANCIAL OFFICER |
(b) | Initial notification/Amendment: INITIAL |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
(a) | Name: REX BIONICS plc |
(b) | LEI: NA |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
(a) | Description of the Financial instrument, type of instrument: Rex Bionics Option over Ordinary Shares of 10p each Identification code: ISIN: GB00BLRLQM66 |
(b) | Nature of the transaction: Issue of awards under Deferred Bonus Share Plan |
(c) | Price(s) and volume(s) Price(s): 10p per Ordinary Share Volume(s): 93,333 |
(d) | Aggregated information · Aggregated volume: 93,333 Ordinary Shares awarded · Price: Exercise price: 10p per Ordinary Share |
(e) | Date of the transaction: 27 September 2016 |
(f) | Place of the transaction: London Stock Exchange - AIM |
1. | Details of the person discharging managerial responsibilities/person closely associated |
(a) | Name: RICHARD LITTLE |
2. | Reason for the notification |
(a) | Position/status: CHIEF TECHNOLOGY OFFICER |
(b) | Initial notification/Amendment: INITIAL |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
(a) | Name: REX BIONICS plc |
(b) | LEI: NA |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
(a) | Description of the Financial instrument, type of instrument: Rex Bionics Option over Ordinary Shares of 10p each Identification code: ISIN: GB00BLRLQM66 |
(b) | Nature of the transaction: Issue of awards under Deferred Bonus Share Plan |
(c) | Price(s) and volume(s) Price(s): 10p per Ordinary Share Volume(s): 134,070 |
(d) | Aggregated information · Aggregated volume: 134,070 Ordinary Shares awarded · Price: Exercise price: 10p per Ordinary Share |
(e) | Date of the transaction: 27 September 2016 |
(f) | Place of the transaction: London Stock Exchange - AIM |
Rex Bionics plc published this content on 27 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 September 2016 12:10:07 UTC.
Original documenthttp://otp.investis.com/clients/uk/union_medtech/rns/regulatory-story.aspx?cid=849&newsid=789843
Public permalinkhttp://www.publicnow.com/view/E712FBC662A11C01A38764A7A90E5F953383E4C0
